Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors.

G. Giaccone; JL Gonzalez-Larriba; A.T. van Oosterom; R Alfonso; E.F. Smit; M. Martens; G.J. Peters; WJ van der Vijgh; R Smith; S Averbuch; A Fandi

doi:https://doi.org/10.1093/annonc/mdh188

Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors.

G. Giaccone, JL Gonzalez-Larriba, A.T. van Oosterom, R Alfonso, E.F. Smit, M. Martens, G.J. Peters, WJ van der Vijgh, R Smith, S Averbuch, A Fandi

Amsterdam UMC

Research output: Contribution to journal › Article › Academic › peer-review

51 Citations (Scopus)

Original language	English
Pages (from-to)	831-8
Journal	Annals of Oncology
Volume	15
Issue number	5
DOIs	https://doi.org/10.1093/annonc/mdh188
Publication status	Published - 2004

Access to Document

https://doi.org/10.1093/annonc/mdh188

Cite this

Giaccone, G., Gonzalez-Larriba, JL., van Oosterom, A. T., Alfonso, R., Smit, E. F., Martens, M., Peters, G. J., van der Vijgh, WJ., Smith, R., Averbuch, S., & Fandi, A. (2004). Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors. Annals of Oncology, 15(5), 831-8. https://doi.org/10.1093/annonc/mdh188

@article{c9d0e463247d4425a8f356fb3f2b7390,

title = "Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors.",

author = "G. Giaccone and JL Gonzalez-Larriba and {van Oosterom}, A.T. and R Alfonso and E.F. Smit and M. Martens and G.J. Peters and {van der Vijgh}, WJ and R Smith and S Averbuch and A Fandi",

year = "2004",

doi = "https://doi.org/10.1093/annonc/mdh188",

language = "English",

volume = "15",

pages = "831--8",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "5",

}

Giaccone, G, Gonzalez-Larriba, JL, van Oosterom, AT, Alfonso, R, Smit, EF, Martens, M, Peters, GJ, van der Vijgh, WJ, Smith, R, Averbuch, S & Fandi, A 2004, 'Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors.', Annals of Oncology, vol. 15, no. 5, pp. 831-8. https://doi.org/10.1093/annonc/mdh188

TY - JOUR

T1 - Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors.

AU - Giaccone, G.

AU - Gonzalez-Larriba, JL

AU - van Oosterom, A.T.

AU - Alfonso, R

AU - Smit, E.F.

AU - Martens, M.

AU - Peters, G.J.

AU - van der Vijgh, WJ

AU - Smith, R

AU - Averbuch, S

AU - Fandi, A

PY - 2004

Y1 - 2004

U2 - https://doi.org/10.1093/annonc/mdh188

DO - https://doi.org/10.1093/annonc/mdh188

M3 - Article

SN - 0923-7534

VL - 15

SP - 831

EP - 838

JO - Annals of Oncology

JF - Annals of Oncology

IS - 5

ER -